Rare Diseases Getting Attention From Drugmakers -- But At High Costs
The orphan drug market is expanding faster than traditional pharmaceuticals with annual growth averaging 25.8 percent from
rare diseases get attention drugmaker high cost orphan drug market expand fast traditional pharmaceutical annual growth average percent